Neonc Technologies Holdings公司——Neo100二期a阶段试验完成患者招募,中期数据预计2026年8月公布

美股速递
Apr 01

Neonc Technologies Holdings公司宣布,其创新药物Neo100的二期a阶段临床试验已完成全部患者入组工作。该项研究的重要里程碑为后续数据评估奠定基础,中期研究结果预计将于2026年8月正式披露。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10